6y2f

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "6y2f" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6y2f is ON HOLD
+
==Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate (alpha-ketoamide 13b)==
-
 
+
<StructureSection load='6y2f' size='340' side='right'caption='[[6y2f]], [[Resolution|resolution]] 1.95&Aring;' scene=''>
-
Authors: Zhang, L., Lin, D., Sun, X., Hilgenfeld, R.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[6y2f]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6Y2F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6Y2F FirstGlance]. <br>
-
Description: Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate (alpha-ketoamide 13b)
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=O6K:~{tert}-butyl+~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate'>O6K</scene></td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6y2f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6y2f OCA], [http://pdbe.org/6y2f PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6y2f RCSB], [http://www.ebi.ac.uk/pdbsum/6y2f PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6y2f ProSAT]</span></td></tr>
 +
</table>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: Hilgenfeld, R]]
[[Category: Lin, D]]
[[Category: Lin, D]]
-
[[Category: Hilgenfeld, R]]
+
[[Category: Sun, X]]
[[Category: Zhang, L]]
[[Category: Zhang, L]]
-
[[Category: Sun, X]]
+
[[Category: Alpha-ketoamide]]
 +
[[Category: Antiviral]]
 +
[[Category: Drug design]]
 +
[[Category: Novel coronavirus]]
 +
[[Category: Viral protein]]

Revision as of 06:59, 4 March 2020

Crystal structure (monoclinic form) of the complex resulting from the reaction between SARS-CoV-2 (2019-nCoV) main protease and tert-butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate (alpha-ketoamide 13b)

PDB ID 6y2f

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools